AGP Picks
View all

Massachusetts Weekly
Provided by AGP

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 25, 2026

Liberty Defense Expands Aviation Footprint with New HEXWAVE™ Award at Major International Airport
Jun. 25, 2026

Liberty Defense Expands Aviation Footprint with New HEXWAVE™ Award at Major International Airport

Indeterminate GlobeNewswire
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Jun. 25, 2026

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire
Blue Cloud Softech's Strategic Expansion and Positive Market Reception Reinforce Rationale of ConnectM Share Exchange
Jun. 25, 2026

Blue Cloud Softech's Strategic Expansion and Positive Market Reception Reinforce Rationale of ConnectM Share Exchange

Indeterminate GlobeNewswire
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
Jun. 25, 2026

Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program

Indeterminate GlobeNewswire
NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease
Jun. 25, 2026

NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease

Indeterminate GlobeNewswire
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Jun. 25, 2026

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

Indeterminate GlobeNewswire
Byrna Technologies to Report Fiscal Second Quarter 2026 Financial Results on Thursday, July 9, 2026 at 9:00 a.m. ET
Jun. 25, 2026

Byrna Technologies to Report Fiscal Second Quarter 2026 Financial Results on Thursday, July 9, 2026 at 9:00 a.m. ET

Indeterminate GlobeNewswire
Lakeside Software Launches SysTrack Reliability Engineering to Transform Digital Employee Experience
Jun. 25, 2026

Lakeside Software Launches SysTrack Reliability Engineering to Transform Digital Employee Experience

Indeterminate GlobeNewswire
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
Jun. 25, 2026

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Indeterminate GlobeNewswire
Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
Jun. 25, 2026

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Indeterminate GlobeNewswire
Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
Jun. 25, 2026

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Indeterminate GlobeNewswire
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
Jun. 25, 2026

Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

Indeterminate GlobeNewswire
Global Confectionery Ingredients Market to Reach $117.7 Billion by 2030, Driven by Rapid Urbanization and Premium Consumer Demand
Jun. 25, 2026

Global Confectionery Ingredients Market to Reach $117.7 Billion by 2030, Driven by Rapid Urbanization and Premium Consumer Demand

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.